30-11-2015 (Ad hoc press release)

Eckert & Ziegler to sell US seed business


Eckert & Ziegler: Successful performance in first nine months of 2015. Moderate third quarter.


Eckert & Ziegler awards prizes to young nuclear medicine researchers


Dr. Harald Hasselmann appointed as new managing director of Eckert & Ziegler BEBIG


Record quarter despite restructuring expenses

30-06-2015 (Ad hoc press release)

Eckert & Ziegler raises profit expectations

19-05-2015 (Ad hoc press release)

IPSEN to acquire all shares in Octreopharm Sciences GmbH


Eckert & Ziegler: positive start to the year 2015


Eckert & Ziegler’s SagiNova® afterloader receives FDA market clearance


Eckert & Ziegler’s Annual Report 2014: Weak Therapy segment puts a strain on consolidated profit

17-03-2015 (Ad hoc press release)

Eckert & Ziegler to Recommend Dividend Payment

05-01-2015 (Ad hoc press release)

Eckert & Ziegler: Disappointing Radiation Therapy business in Eastern Europe threatens to undermine consolidated profit forecast for 2014